Piperacillin-Tazobactam for Pseudomonas aeruginosa Infection : Clinical Implications of an Extended-Infusion Dosing StrategyLODISE, Thomas P; LOMAESTRO, Ben; DRUSANO, George L et al.Clinical infectious diseases. 2007, Vol 44, Num 3, pp 357-363, issn 1058-4838, 7 p.Article

Relationship between Various Definitions of Prior Antibiotic Exposure and Piperacillin-Tazobactam Resistance among Patients with Respiratory Tract Infections Caused by Pseudomonas aeruginosaPATEL, Nimish; MCNUTT, Louise-Anne; LODISE, Thomas P et al.Antimicrobial agents and chemotherapy. 2008, Vol 52, Num 8, pp 2933-2936, issn 0066-4804, 4 p.Article

Prediction model to identify patients with Staphylococcus aureus bacteremia at risk for methicillin resistanceLODISE, Thomas P; MCKINNON, Peggy S; RYBAK, Michael et al.Infection control and hospital epidemiology. 2003, Vol 24, Num 9, pp 655-661, issn 0899-823X, 7 p.Article

Ceftaroline Fosamil in the Treatment of Community-Acquired Bacterial Pneumonia and Acute Bacterial Skin and Skin Structure InfectionsLODISE, Thomas P; LOW, Donald E.Drugs (Basel). 2012, Vol 72, Num 11, pp 1473-1493, issn 0012-6667, 21 p.Article

Steady-State Plasma Pharmacokinetics of Oral Voriconazole in Obese AdultsPAI, Manjunath P; LODISE, Thomas P.Antimicrobial agents and chemotherapy. 2011, Vol 55, Num 6, pp 2601-2605, issn 0066-4804, 5 p.Article

Oseltamivir and Oseltamivir Carboxylate Pharmacokinetics in Obese Adults: Dose Modification for Weight Is Not NecessaryPAI, Manjunath P; LODISE, Thomas P.Antimicrobial agents and chemotherapy. 2011, Vol 55, Num 12, pp 5640-5645, issn 0066-4804, 6 p.Article

Burden of methicillin-resistant Staphylococcus aureus : Focus on clinical and economic outcomesLODISE, Thomas P; MCKINNON, Peggy S.Pharmacotherapy. 2007, Vol 27, Num 7, pp 1001-1012, issn 0277-0008, 12 p.Article

Clinical and economic impact of methicillin resistance in patients with Staphylococcus aureus bacteremiaLODISE, Thomas P; MCKINNON, Peggy S.Diagnostic microbiology and infectious disease. 2005, Vol 52, Num 2, pp 113-122, issn 0732-8893, 10 p.Article

Use of Pharmacokinetic/Pharmacodynamic Systems Analyses to Inform Dose Selection of Tedizolid PhosphateLODISE, Thomas P; DRUSANO, G. L.Clinical infectious diseases. 2014, Vol 58, issn 1058-4838, S28-S34, SUP1Article

Telavancin Penetration into Human Epithelial Lining Fluid Determined by Population Pharmacokinetic Modeling and Monte Carlo SimulationLODISE, Thomas P; GOTFRIED, Mark; BARRIERE, Steven et al.Antimicrobial agents and chemotherapy. 2008, Vol 52, Num 7, pp 2300-2304, issn 0066-4804, 5 p.Article

Application of antimicrobial pharmacodynamic concepts into clinical practice: Focus on β-lactam antibiotics : Insights from the society of infectious diseases pharmacistsLODISE, Thomas P; LOMAESTRO, Ben M; DRUSANO, George L et al.Pharmacotherapy. 2006, Vol 26, Num 9, pp 1320-1332, issn 0277-0008, 13 p.Article

Larger Vancomycin Doses (at Least Four Grams per Day) Are Associated with an Increased Incidence of NephrotoxicityLODISE, Thomas P; LOMAESTRO, Ben; GRAVES, Jeffrey et al.Antimicrobial agents and chemotherapy. 2008, Vol 52, Num 4, pp 1330-1336, issn 0066-4804, 7 p.Article

Risk Factors for Hyperglycemia in Hospitalized Adults Receiving Gatifloxacin : A Retrospective, Nested Case-Controlled AnalysisMOHR, John F; PEYMANN, Patti J; TROXELL, Eric et al.Clinical therapeutics. 2008, Vol 30, Num 1, pp 152-157, issn 0149-2918, 6 p.Article

Identification of patients with Pseudomonas aeruginosa Respiratory tract infections at greatest risk of infection with carbapenem-resistant isolatesLODISE, Thomas P; MILLER, Chris; PATEL, Nimish et al.Infection control and hospital epidemiology. 2007, Vol 28, Num 8, pp 959-965, issn 0899-823X, 7 p.Article

Fluoroquinolone resistance in Streptococcus pneumoniae : Area under the concentration-time curve/MIC ratio and resistance development with gatifloxacin, gemifloxacin, levofloxacin, and moxifloxacinLAPLANTE, Kerry L; RYBAK, Michael J; TSUJI, Brian et al.Antimicrobial agents and chemotherapy. 2007, Vol 51, Num 4, pp 1315-1320, issn 0066-4804, 6 p.Article

Prevalence and risk factors for clinically significant drug interactions with antiretroviral therapyMILLER, Christopher D; EL-KHOLI, Ramy; FARAGON, John J et al.Pharmacotherapy. 2007, Vol 27, Num 10, pp 1379-1386, issn 0277-0008, 8 p.Article

Outcomes analysis of delayed antibiotic treatment for hospital-acquired Staphylococcus aureus bacteremiaLODISE, Thomas P; MCKINNON, Peggy S; SWIDERSKI, Linda et al.Clinical infectious diseases. 2003, Vol 36, Num 11, pp 1418-1423, issn 1058-4838, 6 p.Article

Determination of antibiotic dosage adjustments in patients with renal impairment: elements for successPATEL, Nimish; SCHEETZ, Marc H; DRUSANO, George L et al.Journal of antimicrobial chemotherapy (Print). 2010, Vol 65, Num 11, pp 2285-2290, issn 0305-7453, 6 p.Article

Relationship between Initial Vancomycin Concentration-Time Profile and Nephrotoxicity among Hospitalized PatientsLODISE, Thomas P; PATEL, Nimish; LOMAESTRO, Ben M et al.Clinical infectious diseases. 2009, Vol 49, Num 4, pp 507-514, issn 1058-4838, 8 p.Article

Comparison of β-lactam and macrolide combination therapy versus fluoroquinolone monotherapy in hospitalized veterans affairs patients with community-acquired pneumoniaLODISE, Thomas P; KWA, Andrea; COSLER, Leon et al.Antimicrobial agents and chemotherapy. 2007, Vol 51, Num 11, pp 3977-3982, issn 0066-4804, 6 p.Article

Impact of empirical-therapy selection on outcomes of intravenous drug users with infective endocarditis caused by methicillin-susceptible Staphylococcus aureusLODISE, Thomas P; MCKINNON, Peggy S; LEVINE, Donald P et al.Antimicrobial agents and chemotherapy. 2007, Vol 51, Num 10, pp 3731-3733, issn 0066-4804, 3 p.Article

Pharmacodynamic profiling of piperacillin in the presence of tazobactam in patients through the use of population pharmacokinetic models and Monte Carlo simulationLODISE, Thomas P; LOMAESTRO, Ben; RODVOLD, Keith A et al.Antimicrobial agents and chemotherapy. 2004, Vol 48, Num 12, pp 4718-4724, issn 0066-4804, 7 p.Article

Reevaluation of Ceftazidime Dosing Recommendations in Patients on Continuous Ambulatory Peritoneal DialysisCARDONE, Katie E; GRABE, Darren W; ZASOWSKI, Evan J et al.Antimicrobial agents and chemotherapy. 2014, Vol 58, Num 1, pp 19-26, issn 0066-4804, 8 p.Article

Clinical outcomes for patients with bacteremia caused by vancomycin-resistant enterococcus in a level 1 trauma centerLODISE, Thomas P; MCKINNON, Peggy S; TAM, Vincent H et al.Clinical infectious diseases. 2002, Vol 34, Num 7, pp 922-929, issn 1058-4838Article

Vancomycin Exposure in Patients With Methicillin-Resistant Staphylococcus aureus Bloodstream Infections: How Much Is Enough?LODISE, Thomas P; DRUSANO, George L; ZASOWSKI, Evan et al.Clinical infectious diseases. 2014, Vol 59, Num 5, pp 666-675, issn 1058-4838, 10 p.Article